Simcere Zaiming Pharmaceutical Co., Ltd. — insider trades

Stock trades Simcere Zaiming Pharmaceutical Co., Ltd. reported on SEC Form 4 at NXTC NextCure, Inc..

• Aug 10, 2026: sold 30,000 shares of NXTC NextCure, Inc. ($185K)